Focus: Dyno Therapeutics is an AAV engineering specialist focused on gene therapy, leveraging AI-powered computational biology to design novel capsids and improve viral delivery. Founded in 2016 and headquartered in Watertown, MA, the company operates at the intersection of synthetic biology and machine learning.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Stable — net -2 jobs in 30d
0 added, 2 removed. Backfill posture.
Dyno is a high-upside, specialized bet for engineers and data scientists willing to trade breadth and clinical exposure for cutting-edge platform IP and licensing economics.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Dyno Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Dyno Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 9 publications